A New Baltimore pharmacist who operates a pharmacy in Grosse Pointe has been indicted by the federal government on charges that she filled hundreds of prescriptions for illicit opioids approved by doctors involved in a prescription forgery ring.
Hasna Bashir Iwas, 60, owner of Beacon Pointe Pharmacy on Jefferson Avenue in Grosse Pointe Park, was indicted in U.S. District Court Thursday for distribution of prescription drug-controlled substances, conspiracy and maintenance illegal from a local containing drugs, Acting US Attorney Saima told Mohsin.
The superseding indictment adds the accused to previous indictments that accused Dr. Otis Crawford and three other accused of operating a prescription drug network in Detroit, Grosse Pointe Park, River Rouge and elsewhere, have US prosecutors said.
Crawford pleaded guilty to the counts in the previous indictment, but died of natural causes before being sentenced, officials said.
This indictment alleges that I have filled hundreds of fraudulent prescriptions issued by the Crawford Clinic for drugs such as Oxycodone, Hydrocodone, Xanax and Promethazine with codeine syrup. Crawford’s orders had an estimated market value of over $ 2 million, officials said. In addition, she filled over 600 forged prescriptions under the names of various doctors for the Counterfeit Network operating in Detroit, charging money to fill the fake prescriptions even when the so-called “patient” had insurance. officials said.
I claimed that she still required the patient to be present to fill her controlled substance prescription and denied filling the prescriptions of a “runner” who approached her with a bunch of counterfeiters, federal authorities said. . But one of the bogus prescriptions incriminated in the indictment was executed the day after the alleged patient was murdered, officials said.
“We will continue to hold medical professionals who seek to enrich themselves by illegally distributing controlled substances to account,” Interim US Attorney Mohsin said. “Our commitment to tackling the opioid crisis is unwavering. “
“Distributing controlled substances is a privilege that requires compliance with the law,” said Special Agent in Charge Martin. “The DEA is committed to ensuring that those who are committed to obeying our country’s drug laws fulfill this responsibility.”
Iwas is scheduled to appear in federal court on October 1.
The case has been investigated by the Drug Enforcement Administration and is being pursued by Assistant US Attorney Wayne F. Pratt.